0001209191-21-060022.txt : 20211008 0001209191-21-060022.hdr.sgml : 20211008 20211008160019 ACCESSION NUMBER: 0001209191-21-060022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211008 DATE AS OF CHANGE: 20211008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PASSERI DANIEL R CENTRAL INDEX KEY: 0001190121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 211315310 MAIL ADDRESS: STREET 1: C/O CURIS INC STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-30 0 0001645460 Cue Biopharma, Inc. CUE 0001190121 PASSERI DANIEL R C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 1 0 0 CHIEF EXECUTIVE OFFICER Common Stock 2021-09-30 4 M 0 75000 A 130377 D Common Stock 2021-09-30 4 F 0 31677 14.57 D 98700 D Restricted Stock Units 2021-09-30 4 M 0 75000 0.00 D Common Stock 75000 75000 D Represents shares of common stock received upon vesting of a restricted stock unit award. Each restricted stock unit award represents a contingent right to receive one share of common stock. One half of the Restricted Stock Units vested on September 30, 2021 and the balance will vest on March 31, 2022. /s/ Daniel Passeri by Colin Sandercock, attorney-in-fact 2021-10-08